Clinical Trial Update: Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This study evaluated escalating doses of intensity-modulated radiotherapy in patients with unresectable pancreatic cancer across Phase 1 and Phase 2, and the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-08-27